Genpact (NYSE:G – Free Report) had its price target lowered by JPMorgan Chase & Co. from $46.00 to $40.00 in a research note published on Thursday, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the business services provider’s stock. Other equities research analysts also recently issued research reports about the company. […]